Slaughter and May advises ELIQUENT Life Sciences and GHO Capital Partners LLP on the acquisition of RApport Global Strategic Services

Slaughter and May advised ELIQUENT Life Sciences (“ELIQUENT”) (formerly Validant) and GHO Capital Partners LLP (“GHO”) on ELIQUENT’s acquisition of RApport Global Strategic Services, a UK-based international regulatory consultancy supporting life science innovators and providing regulatory support to the pharmaceutical, biotechnological and medical device industries.

ELIQUENT is a global regulatory consulting firm for the life sciences industry whose growth strategy is supported by GHO, a leading specialist healthcare investment advisor based in London which has partnered with ELIQUENT since December 2018.

Corporate/Private Equity
Harry Bacon Partner
Jack Hull Associate
Angus Higgins Associate
Kate Merry Associate
Pensions, Employment, and Incentives
Charles Osborne Partner
Andrew McCue Associate
Kerry O'Connell Partner
Jack Dickie Associate
Laura Houston Partner
Issabella Cardu Associate
Real Estate
John Nevin Partner
Emily AlHamarneh Associate